11 research outputs found
Evaluation of prophylaxis in primary prevention with acetylsalicylic acid in people with diabetes: A scoping review
The efficacy and safety of acetylsalicylic acid (ASA) prophylaxis for the primary
prevention of atherosclerotic cardiovascular disease (ACVD) remain controversial in people with
diabetes (DM) without ACVD, because the possible increased risk of major bleeding could outweigh the potential reduction in the risk of mortality and of major adverse cardiovascular events
(MACE) considered individually or together.La eficacia y la seguridad de la profilaxis con ácido acetilsalicílico (AAS) para la prevención primaria de la enfermedad cardiovascular arteriosclerótica (ECVA) siguen siendo controvertidas en personas con diabetes (DM) sin ECVA, ya que el posible aumento del riesgo de hemorragias graves podría superar la posible disminución del riesgo de mortalidad y de los principales episodios adversos cardiovasculares (MACE) considerados individualmente o en conjunto